BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 16084755)

  • 1. Oral malignancies following HSCT: graft versus host disease and other risk factors.
    Demarosi F; Lodi G; Carrassi A; Soligo D; Sardella A
    Oral Oncol; 2005 Oct; 41(9):865-77. PubMed ID: 16084755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Squamous cell carcinoma of the oral cavity associated with graft versus host disease: report of a case and review of the literature.
    Demarosi F; Soligo D; Lodi G; Moneghini L; Sardella A; Carrassi A
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Jul; 100(1):63-9. PubMed ID: 15953918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High incidence of oral squamous cell carcinoma independent of HPV infection after allogeneic hematopoietic SCT in Taiwan.
    Chen MH; Chang PM; Li WY; Hsiao LT; Hong YC; Liu CY; Gau JP; Liu JH; Chen PM; Chiou TJ; Tzeng CH
    Bone Marrow Transplant; 2011 Apr; 46(4):567-72. PubMed ID: 20622906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solid tumors after hematopoietic stem cell transplantation in Japan: incidence, risk factors and prognosis.
    Shimada K; Yokozawa T; Atsuta Y; Kohno A; Maruyama F; Yano K; Taji H; Kitaori K; Goto S; Iida H; Morishima Y; Kodera Y; Naoe T; Morishita Y
    Bone Marrow Transplant; 2005 Jul; 36(2):115-21. PubMed ID: 15908969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High incidence of invasive aspergillosis associated with intestinal graft-versus-host disease following nonmyeloablative transplantation.
    Labbé AC; Su SH; Laverdière M; Pépin J; Patiño C; Cohen S; Kiss T; Lachance S; Sauvageau G; Busque L; Roy DC; Roy J
    Biol Blood Marrow Transplant; 2007 Oct; 13(10):1192-200. PubMed ID: 17889356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Squamous cell carcinoma of the tongue complicating chronic oral mucosal graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Szeto CH; Shek TW; Lie AK; Au WY; Yuen AP; Kwong YL
    Am J Hematol; 2004 Oct; 77(2):200-2. PubMed ID: 15389910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An overview of chronic oral graft-vs-host disease following pediatric hematopoietic stem cell transplantation.
    da Fonseca MA; Hong C
    Pediatr Dent; 2008; 30(2):98-104. PubMed ID: 18481573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Head and neck squamous cell carcinoma in 13 patients with Fanconi anemia after hematopoietic stem cell transplantation.
    Masserot C; Peffault de Latour R; Rocha V; Leblanc T; Rigolet A; Pascal F; Janin A; Soulier J; Gluckman E; Socié G
    Cancer; 2008 Dec; 113(12):3315-22. PubMed ID: 18831513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple squamous cell carcinomas of the oral cavity in a young patient with graft-versus-host disease following allogenic bone marrow transplantation.
    Montebugnoli L; Gissi DB; Marchetti C; Foschini MP
    Int J Oral Maxillofac Surg; 2011 May; 40(5):556-8. PubMed ID: 21163622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk for secondary thyroid carcinoma after hematopoietic stem-cell transplantation: an EBMT Late Effects Working Party Study.
    Cohen A; Rovelli A; Merlo DF; van Lint MT; Lanino E; Bresters D; Ceppi M; Bocchini V; Tichelli A; Socié G
    J Clin Oncol; 2007 Jun; 25(17):2449-54. PubMed ID: 17557958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Second solid cancers after allogeneic hematopoietic stem cell transplantation.
    Gallagher G; Forrest DL
    Cancer; 2007 Jan; 109(1):84-92. PubMed ID: 17131350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Liver biopsy in the management of liver dysfunction after allogeneic hematopoietic stem-cell transplantation].
    Chen H; Huang XJ; Liu KY; Xu LP; Wang H; Liu DH; Lu J; Lu DP
    Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(43):3062-6. PubMed ID: 16324408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical analysis of late-onset nephrotic syndrome after allogenic hematopoietic stem cell transplantation].
    Luo XD; Liu QF; Ning J; Wei YQ; Fan ZP; Zhang Y; Sun J
    Zhonghua Yi Xue Za Zhi; 2007 Dec; 87(46):3280-3. PubMed ID: 18396625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoimmune hemolytic anemia following allogeneic hematopoietic stem cell transplantation in adult patients.
    Sanz J; Arriaga F; Montesinos P; Ortí G; Lorenzo I; Cantero S; Puig N; Moscardó F; de la Rubia J; Sanz G; Sanz MA
    Bone Marrow Transplant; 2007 May; 39(9):555-61. PubMed ID: 17351645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary Nocardia and Aspergillus co-infection in a patient with chronic graft-versus-host disease.
    Hamadani M; Benson DM; Blum W; Garzon R; Devine SM
    Transpl Infect Dis; 2008 Feb; 10(1):24-6. PubMed ID: 17651365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of IL-18 and sIL2R on aGVHD occurrence after hematopoietic stem cell transplantation in some Iranian patients.
    Shaiegan M; Iravani M; Babaee GR; Ghavamzadeh A
    Transpl Immunol; 2006 Jan; 15(3):223-7. PubMed ID: 16431290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for late infections after allogeneic hematopoietic stem cell transplantation from a matched related donor.
    Robin M; Porcher R; De Castro Araujo R; de Latour RP; Devergie A; Rocha V; Larghero J; Adès L; Ribaud P; Mary JY; Socié G
    Biol Blood Marrow Transplant; 2007 Nov; 13(11):1304-12. PubMed ID: 17950917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemorrhagic cystitis following hematopoietic stem cell transplantation: incidence, risk factors and association with CMV reactivation and graft-versus-host disease.
    Xu LP; Zhang HY; Huang XJ; Liu KY; Liu DH; Han W; Chen H; Chen YH; Gao ZY; Zhang YC; Lu DP
    Chin Med J (Engl); 2007 Oct; 120(19):1666-71. PubMed ID: 17935666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factor analysis for thrombotic microangiopathy after reduced-intensity or myeloablative allogeneic hematopoietic stem cell transplantation.
    Nakamae H; Yamane T; Hasegawa T; Nakamae M; Terada Y; Hagihara K; Ohta K; Hino M
    Am J Hematol; 2006 Jul; 81(7):525-31. PubMed ID: 16755559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.